股本结构
单位：万股
| 公告日期 | 2024-03-25 | 2024-03-22 | 2024-02-08 | 2024-03-22 | 2023-11-14 | 2023-11-14 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3363.13 | 3057.67 | 3038.19 | 2993.00 | 2927.27 | 2927.30 |
| 普通股本 | 3363.13 | 3057.67 | 3038.19 | 2993.00 | 2927.27 | 2927.30 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-27 | 2024-03-18 | 2024-01-31 | 2023-12-31 | 2023-11-10 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-03-25 | 3363.13 | 未披露 |
更多>>
Common stock offered 3,054,609 shares by the company
|
2024-03-27 |
| 2024-03-22 | 3057.67 | 未披露 | 定期报告 | 2024-03-18 |
| 2024-02-08 | 3038.19 | 未披露 | 定期报告 | 2024-01-31 |
| 2024-03-22 | 2993.00 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock, net of offering costs
Exercise of stock options
Vesting of restricted stock units, net of employee tax obligations
|
2023-12-31 |
| 2023-11-14 | 2927.27 | 未披露 | 定期报告 | 2023-11-10 |
| 2023-11-14 | 2927.30 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Vesting of restricted stock units, net of employee tax obligations
|
2023-09-30 |
| 2023-11-14 | 2926.72 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of stock options
Vesting of restricted stock units, net of employee tax obligations
|
2023-06-30 |
| 2023-05-01 | 2915.96 | 未披露 | 定期报告 | 2023-04-27 |
| 2023-05-09 | 2910.00 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common shares, net of offering costs
Exercise of stock options
Vesting of restricted stock units, net of employee tax obligations
|
2023-03-31 |
| 2023-03-16 | 2900.95 | 未披露 | 定期报告 | 2023-03-13 |
| 2023-03-16 | 2814.70 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Exercise of stock options
|
2022-12-31 |
| 2022-11-14 | 2802.32 | 未披露 | 定期报告 | 2022-11-07 |
| 2022-11-14 | 2802.30 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Exercise of stock options
|
2022-09-30 |
| 2022-08-11 | 2802.25 | 未披露 | 定期报告 | 2022-08-08 |
| 2022-08-11 | 2801.80 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Exercise of stock options
|
2022-06-30 |
| 2022-05-09 | 2798.51 | 未披露 | 定期报告 | 2022-05-05 |
| 2022-05-09 | 2798.00 | 未披露 | 定期报告 | 2022-03-31 |
| 2022-03-11 | 2798.03 | 未披露 | 定期报告 | 2022-03-01 |
| 2022-03-11 | 2798.00 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Exercise of stock options
Issuance of common shares, net of issuance costs of $3,542
|
2021-12-31 |
| 2021-11-10 | 2798.03 | 未披露 | 定期报告 | 2021-11-05 |
| 2021-11-10 | 2798.00 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of stock options
|
2021-09-30 |
| 2021-08-10 | 2796.90 | 未披露 | 定期报告 | 2021-08-05 |
| 2021-08-10 | 2796.90 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock, net of issuance costs of $3,542
Exercise of stock options
|
2021-06-30 |
| 2021-06-25 | 2778.66 | 未披露 |
更多>>
1.Common stock offered 3,155,000 shares
2.The number of shares of common stock to be outstanding immediately after this offering is based on 24,631,573 shares of common stock outstanding as of March 31, 2021.
|
2021-06-25 |
| 2021-05-10 | 2463.20 | 未披露 | 定期报告 | 2021-05-05 |
| 2021-05-10 | 2463.10 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Exercise of stock options
|
2021-03-31 |
| 2021-03-12 | 2457.30 | 未披露 | 定期报告 | 2021-03-01 |
| 2021-03-12 | 2441.70 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common shares, net of issuance costs of $17,815
Purchase and cancellation of shares from BioXcel Corporation
Exercise of stock options
|
2020-12-31 |
| 2020-11-12 | 2436.84 | 未披露 | 定期报告 | 2020-11-01 |
| 2020-11-12 | 2435.49 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common stock, net of issuance costs of $12,991
Exercise of stock options
|
2020-09-30 |
| 2020-08-14 | 2235.49 | 未披露 | 定期报告 | 2020-08-11 |
| 2020-07-31 | 2418.24 | 未披露 |
更多>>
1.Common stock offered by the company 4,000,000 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 20,182,382 shares of common stock outstanding as of March 31, 2020.
|
2020-07-31 |
| 2020-08-14 | 2035.29 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Exercise of stock options
|
2020-06-30 |
| 2020-05-12 | 2021.13 | 未披露 | 定期报告 | 2020-05-04 |
| 2020-05-12 | 2018.24 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock, net of issuance costs of $4,789
Purchase and cancellation of shares from BioXcel Corporation
Exercise of stock options
|
2020-03-31 |
| 2020-03-09 | 2018.24 | 未披露 | 定期报告 | 2020-03-09 |
| 2020-02-24 | 2008.74 | 未披露 | 定期报告 | 2020-02-24 |
| 2020-03-09 | 1808.74 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of common stock, net of issuance costs of $1,991
Exercise of stock options
|
2019-12-31 |
| 2019-11-14 | 1803.50 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Issuance of common shares, net of issuance costs of $1,991
|
2019-09-30 |
| 2019-09-25 | 1573.20 | 未披露 | 定期报告 | 2019-08-31 |
| 2019-08-06 | 1573.14 | 未披露 | 定期报告 | 2019-07-31 |
| 2019-08-06 | 1568.75 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Issuance of common shares, net of issuance costs of $11
|
2019-06-30 |
| 2019-05-07 | 1566.58 | 未披露 |
更多>>
From December 31, 2018 to March 26, 2019
Exercise of stock options
|
2019-03-26 |
| 2019-03-12 | 1566.32 | 未披露 |
更多>>
From December 31, 2017 to December 31, 2018
Issuance of common shares
Issuance of common shares, upon completion of Initial Public Offering, net of issuance costs of $5,898
Exercise of stock options
|
2018-12-31 |
| 2018-05-14 | 1564.55 | 未披露 |
更多>>
From January 1, 2018 to March 31, 2018
Issuance of common shares
Issuance of common shares, upon completion of Initial Public Offering, net of issuance costs of $5,898
|
2018-03-31 |
| 2018-03-09 | 1564.55 | 未披露 |
更多>>
1.Common stock offered 5,454,545 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 9,907,548 shares of our common stock outstanding as of December 31, 2017
3.a 237-for-1 stock split of our common stock effected on March 7, 2018
|
2018-03-08 |
| 2018-02-12 | 4.18 | 未披露 | 定期报告 | 2017-12-31 |
Common stock offered 3,054,609 shares by the company
From December 31, 2022 to December 31, 2023
Issuance of common stock, net of offering costs
Exercise of stock options
Vesting of restricted stock units, net of employee tax obligations
From June 30, 2023 to September 30, 2023
Vesting of restricted stock units, net of employee tax obligations
From March 31, 2023 to June 30, 2023
Exercise of stock options
Vesting of restricted stock units, net of employee tax obligations
From December 31, 2022 to March 31, 2023
Issuance of common shares, net of offering costs
Exercise of stock options
Vesting of restricted stock units, net of employee tax obligations
From December 31, 2021 to December 31, 2022
Exercise of stock options
From June 30, 2022 to September 30, 2022
Exercise of stock options
From March 31, 2022 to June 30, 2022
Exercise of stock options
From December 31, 2020 to December 31, 2021
Exercise of stock options
Issuance of common shares, net of issuance costs of $3,542
From June 30, 2021 to September 30, 2021
Exercise of stock options
From March 31, 2021 to June 30, 2021
Issuance of common stock, net of issuance costs of $3,542
Exercise of stock options
1.Common stock offered 3,155,000 shares
2.The number of shares of common stock to be outstanding immediately after this offering is based on 24,631,573 shares of common stock outstanding as of March 31, 2021.
From December 31, 2020 To March 31, 2021
Exercise of stock options
From December 31, 2019 to December 31, 2020
Issuance of common shares, net of issuance costs of $17,815
Purchase and cancellation of shares from BioXcel Corporation
Exercise of stock options
From June 30, 2020 to September 30, 2020
Issuance of common stock, net of issuance costs of $12,991
Exercise of stock options
1.Common stock offered by the company 4,000,000 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 20,182,382 shares of common stock outstanding as of March 31, 2020.
From March 31, 2020 to June 30, 2020
Exercise of stock options
From December 31, 2019 to March 31, 2020
Issuance of common stock, net of issuance costs of $4,789
Purchase and cancellation of shares from BioXcel Corporation
Exercise of stock options
From December 31, 2018 to December 31, 2019
Issuance of common stock, net of issuance costs of $1,991
Exercise of stock options
from June 30, 2019 to September 30, 2019
Issuance of common shares, net of issuance costs of $1,991
From March 31, 2019 to June 30, 2019
Issuance of common shares, net of issuance costs of $11
From December 31, 2018 to March 26, 2019
Exercise of stock options
From December 31, 2017 to December 31, 2018
Issuance of common shares
Issuance of common shares, upon completion of Initial Public Offering, net of issuance costs of $5,898
Exercise of stock options
From January 1, 2018 to March 31, 2018
Issuance of common shares
Issuance of common shares, upon completion of Initial Public Offering, net of issuance costs of $5,898
1.Common stock offered 5,454,545 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 9,907,548 shares of our common stock outstanding as of December 31, 2017
3.a 237-for-1 stock split of our common stock effected on March 7, 2018